Karla Hurt

The Effect of Abemaciclib Plus Fulvestrant on Overall Survival in Hormone Receptor–Positive, ERBB2-Negative Breast Cancer That Progressed on Endocrine Therapy—MONARCH 2

George W. Sledge, Masakazu Toi, Patrick Neven et al. · JAMA Oncology · 2019 · 987 citations · Full text

Medicine, Oncology, Pharmacology +17

Tirzepatide for Heart Failure with Preserved Ejection Fraction and Obesity

Milton Packer, Michael R. Zile, Christopher M. Kramer et al. · New England Journal of Medicine · 2024 · 783 citations

Pharmacy, Cardiology, Pharmacotherapy +17

Tirzepatide Reduces LV Mass and Paracardiac Adipose Tissue in Obesity-Related Heart Failure

Christopher M. Kramer, Barry A. Borlaug, Michael R. Zile et al. · Journal of the American College of Cardiology · 2024 · 142 citations · Full text

Medicine, Cardiology, Pharmacotherapy +12

Effects of tirzepatide on circulatory overload and end-organ damage in heart failure with preserved ejection fraction and obesity: a secondary analysis of the SUMMIT trial

Barry A. Borlaug, Michael R. Zile, Christopher M. Kramer et al. · Nature Medicine · 2024 · 118 citations · Full text

Medicine, Cardiology, Pharmacology +15

A Randomised Phase 2 Study Combining LY2181308 Sodium (Survivin Antisense Oligonucleotide) with First-line Docetaxel/Prednisone in Patients with Castration-resistant Prostate Cancer

Paweł Wiechno, Bradley G. Somer, Begoña Mellado et al. · European Urology · 2013 · 79 citations · Full text

Medicine, Oncology, Pharmacology +13